Stockwinners Market Radar for December 29, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

RTN

Hot Stocks

17:37 EDT Raytheon awarded $333.35M government contract - Raytheon has been awarded a $333.35M firm-fixed-price, cost-plus-fixed-fee contract for a Surveillance Radar program operations and maintenance follow-on sustainment package that includes contractor logistics support; engineering services and technical updates to address equipment obsolescence; transportation and material costs associated with contractor repair and return services; spare and repair parts; support and test equipment; publications and technical documentation personnel training and training equipment; government and contractor engineering; technical and logistics support services; and other related elements of logistical and program support.
TCF

Hot Stocks

17:21 EDT TCF Financial estimates $120M-$140M tax benefit, gives 80% of workforce bonuses - TCF Financial announced that as a result of the tax reform legislation enacted December 22, it will be required to revalue its deferred tax assets and deferred tax liabilities to account for the future impact of lower corporate tax rates on these deferred amounts. Based on preliminary analysis, TCF expects to record a one-time net tax benefit in an estimated amount of between $120M-$140M primarily related to the revaluation of these deferred tax items. This decrease to income tax expense will be reflected in TCF's operating results for Q4. TCF has not completed its processes to determine the actual net tax benefits related to many of the impacted items, and the ultimate amount of the actual net tax benefit will be based upon a number of factors, including final net deferred tax liabilities as of December 31, the completion of TCF's consolidated financial statements as of and for the year ending December 31 and the completion of TCF's 2017 tax returns. As a result of the Tax Cuts and Jobs Act, TCF will provide approximately $5M in one-time bonuses to eligible team members, $1,000 to full-time team members and $500 to part-time team members, who earned less than $100,000 in total compensation during 2017, totaling 80% of its workforce. Additionally, TCF will donate $5M to TCF Foundation to increase grants to nonprofit organizations in the communities it serves, including increasing its match of team member contributions to nonprofit organizations from 100% to 200% in 2018.
NWN

Hot Stocks

17:20 EDT Northwest Natural Gas files for general rate increase in Oregon - Northwest Natural Gas Company announced, for the first time since 2011, the company has filed for a general rate increase with the Public Utility Commission of Oregon. If approved as filed, the request would result in a net revenue increase of $40.4M or about 6% after an adjustment for the conservation tariff deferral. The request covers costs associated with operating and maintaining the company's natural gas distribution system, and continuing to provide safe and reliable service to customers. Under the proposal, a residential customer using 53 therms per month would see an average monthly bill increase of about $5. A commercial customer using 238 therms per month would see an average monthly bill increase of about $15. The request will not affect customer bills for the 2017-2018 winter season.
NYRT

Hot Stocks

17:15 EDT Davidson Kempner reports 7.1% passive stake in New York REIT
TCCO

Hot Stocks

17:00 EDT Technical Communications trading resumes
GALE

Hot Stocks

16:55 EDT Galena to merge with SELLAS, will trade under SLS - SELLAS Life Sciences announced that the proposed merger of the businesses of SELLAS Life Sciences and Galena Biopharma has closed, following approval by Galena's stockholders. Upon completion of the merger, Galena was renamed SELLAS Life Sciences Group and now features a late-stage pipeline led by novel immunotherapies targeting a broad range of indications in hematologic and solid malignancies. SELLAS is expected to commence trading on the Nasdaq Capital Market on January 2, 2018, under the ticker symbol (SLS).
UCBI

Hot Stocks

16:45 EDT United Community Banks says U.S. Tax Act will hurt Q4 EPS by 48c-53c - In a filing, United Community Banks concluded that the "Tax Cuts and Jobs Act" that was signed into law will cause the company's net deferred tax asset to be revalued. The company's net deferred tax asset represents net operating loss carryforwards that will be used to reduce corporate taxes expected to be paid in the future as well as differences between the carrying amounts and tax bases of assets and liabilities carried on the company's balance sheet. The company performed an analysis to determine the impact of the revaluation of the deferred tax asset. It is estimated that the value of the deferred tax asset will be reduced by a range of approximately $37M-$41M. The estimated Q4 earnings impact would be approximately 48c-53c per share and the estimated tangible book value impact would be approximately 47c-52c per share. The company's revaluation of its net deferred tax asset is subject to further clarifications of the new law that cannot be estimated at this time. As such, the company is unable to make a final determination of the impact on the quarterly and year to date earnings for the period ending December 31, 2017 at this time.
JONE

Hot Stocks

16:34 EDT Jones Energy receives noncompliance notification from NYSE - Jones Energy announced that it received notification on December 26 from the NYSE that the company was noncompliant with certain continued listing standards because the price of the company's Class A common stock over a period of 30 consecutive trading days had fallen below $1.00 per share, which is the minimum average closing price per share required to maintain a listing on the NYSE. As required, the company will submit a letter confirming its receipt of the notice to the NYSE within 10 business days. Jones Energy now has a six-month cure period to regain compliance. Within the cure period, the company may regain compliance if the closing price per share is $1.00 or higher on the last trading day of a given month, or at the end of the cure period. Additionally, the 30-day average closing price per share must also be $1.00 or higher.
TCCO

Hot Stocks

16:25 EDT Technical Communications trading halted, news pending
WFT SLB

Hot Stocks

16:20 EDT Weatherford completes sale of fracking business to Schlumberger subsidiary - Weatherford International (WFT) announced it has sold its U.S. pressure pumping and pump-down perforating assets to a subsidiary of Schlumberger Limited (SLB) for $430M in cash. Weatherford will use the proceeds from the sale to reduce outstanding indebtedness.
ORIG

Hot Stocks

16:20 EDT Ocean Rig UDW announces new CEO, CFO - Ocean Rig UDW announced that Pankaj Khanna has been appointed as president and CEO of the company effective January 1, 2018. Khanna has 29 years of varied experience in the maritime & offshore industry. He last served as CEO of Pioneer Marine. Prior to his position at Pioneer Marine, Khanna served as CMO at Ocean Rig UDW Iraklis Sbarounis has been appointed CFO of the company effective January 1, 2018. Sbarounis will also continue to serve as a director and secretary of the company. Prior to his current positions, he held the position of VP business development at the company. David Cusiter has been appointed as Chief Operations Officer of the company effective November 25.
IBP

Hot Stocks

16:18 EDT Installed Building Products announces two acquisitions - Installed Building Products announced the acquisition of Blind Ambitions. Founded in 2006, Blind Ambitions has multiple locations throughout the southeast. Blind Ambitions specializes in installing blinds, shades and shutters primarily for the new construction homebuilding industry and has trailing-twelve month revenue of $9.4M. In addition to Blind Ambitions, the company acquired Allpro Insulation Co. Founded in 1998, Allpro serves the greater Raleigh market through one branch location. The company primarily provides fiberglass insulation installation services for single-family residential customers and has trailing-twelve month revenue of $2.8M.
ALSK

Hot Stocks

16:17 EDT Alaska Communications responds to shareholder - Alaska Communications issued the following statement in response to the SEC filing by Karen Singer and TAR Holdings, a limited liability company for which Singer is the sole member: "We have held numerous discussions with TAR Holdings since it first initiated its investment in Alaska Communications to understand its perspective on Alaska Communications' long-term growth plan, including any suggestions and alternate strategies it may have for enhancing value for all Alaska Communications stockholders. In our discussions with TAR Holdings, its singular focus has been that Alaska Communications should immediately publicly announce a process to explore the sale of Alaska Communications. We have been clear in our discussions with TAR Holdings that our Board and management team are not opposed to any transaction that creates or unlocks value for all our stockholders. However, it is important that any process to explore such a transaction be appropriately managed and undertaken in an orderly manner. We believe that any process that creates uncertainty for our customers and employees will only detract from our ongoing initiatives to enhance and unlock stockholder value harming the future prospects of Alaska Communications and, ultimately, could adversely affect our ability to maximize value for all our stockholders. Our Board has seven highly qualified and very experienced directors, six of whom are independent and bring a wealth of experience in our sector, in M&A transactions, and in doing business in Alaska. Our Board is actively engaged and, accordingly, there is strong independent director oversight to ensure that management executes on our strategic growth plan and our ongoing initiatives to enhance and unlock shareholder value. As part of such a plan, which our Board believes is in the best interests of all Alaska Communications shareholders, our Board regularly considers, with the assistance of its financial and legal advisors, strategic and value creation alternatives. We remain committed to running a quality business that allows us to retain our talent, fosters trust with our customers, and enables us to win in the market, while we remain open to considering all available options to create and unlock stockholder value for the benefit of all our stockholders."
ALSK

Hot Stocks

16:16 EDT Alaska Communications shareholder to put up opposing slate to run against board - In a filing, Karen Singer voiced outrage at, among other things, the implementation of the purported adoption by Alaska Communications of the amended bylaws on December 22. Singer has attempted to engage with management to discuss strategic alternatives for the benefit of the company's shareholders. Among other things, Singer has requested that the company retain a financial advisor to review such strategic alternatives. In response to such request, the company and its current management have purported to implement an improper and inappropriate amended bylaws change which appears intended to entrench management and the company's board to the detriment of shareholders. As a consequence, the company has given Singer no alternative but to put up an opposing slate to run against the current board at the upcoming annual meeting of Alaska Communications shareholders.
EDGE

Hot Stocks

16:14 EDT Edge Therapeutics Phase 3 NEWTON 2 study to continue as planned - Edge Therapeutics announced that an independent Data Monitoring Committee, or DMC, recommended that the Phase 3 NEWTON 2 study of EG-1962 continue as planned based on the completion of a pre-planned futility analysis. The DMC made this recommendation after evaluating data from the day 90 follow-up visit of the first 150 patients randomized and treated, as well as the available safety data in the study. The pivotal, Phase 3 NEWTON 2 study is comparing the efficacy and safety of EG-1962 compared to standard of care oral nimodipine in up to approximately 374 adult patients with aneurysmal subarachnoid hemorrhage. Patients in the experimental arm receive a single 600 mg intraventricular injection of EG-1962 plus placebo capsules or tablets administered for up to 21 days. Patients in the active comparator arm receive a single dose of intraventricular normal saline and up to 21 days of oral nimodipine capsules or tablets. The primary outcome measure is the proportion of patients with a favorable outcome of six to eight on the Extended Glasgow Outcome Scale at the day 90 visit. Additional measures are neurocognitive outcome at day 90 assessed by the Montreal Cognitive Assessment safety and health economic endpoints
CTRV

Hot Stocks

16:10 EDT ContraVir Pharmaceuticals CMO John Sullivan-Bolyai to step down - ContraVir Pharmaceuticals announced that John Sullivan-Bolyai will step down as CMO and take on a new role in the company, effective December 29. Sullivan-Bolyai will serve as a part-time consultant to the company, where he will remain involved in key strategic decisions, as well as medical and clinical affairs.
BPTH

Hot Stocks

16:07 EDT Bio-Path Holdings provides update on current and upcoming studies - Bio-Path Holdings provided an update from several clinical programs and provided a 2018 business overview. Bio-Path is conducting a Phase 2 clinical trial of its lead drug candidate, prexigebersen, in combination with frontline therapy low dose cytarabine in de novo acute myeloid leukemia patients who are ineligible or unwilling to undergo intensive induction therapy. The single arm trial is designed for up to 54 evaluable patients with an interim analysis performed after 19 patients. To-date in this study, over 50 potential patients have been pre-screened, 26 patients have been screened, 23 patients have been enrolled and 17 patients have been deemed evaluable with 6 additional patients currently undergoing treatment. Bio-Path expects the 19 patient pre-specified analysis to be completed in early 2018, at which time the assessment of these patients will be addressed by Bio-Path.Plans for a pivotal trial will be discussed with the FDA if these results exceed expectations for current standard of care therapy. Bio-Path today announces the initiation of its Phase 2a clinical study of prexigebersen for the treatment of chronic myeloid leukemia, or CML. The trial is being conducted as a potential salvage therapy for accelerated and blast phase CML patients. Two cohorts of three evaluable patients each will be enrolled to evaluate two doses of prexigebersen in combination with the front-line treatment dasatinib. In 2018, Bio-Path intends to initiate a Phase 1 clinical trial of BP1002, an antisense RNAi nanoparticle targeting the Bcl-2 protein, in refractory or relapsed lymphoma patients. The clinical trial would evaluate the safety of BP1002 in several dose escalating cohorts to determine a maximum tolerated dose and/or optimal biologically active dose.
BCR

Hot Stocks

15:57 EDT C.R. Bard trading resumes
TMO

Hot Stocks

15:56 EDT Thermo Fisher completes acquisition of Phenom-World - Thermo Fisher Scientific announced it has completed the acquisition of Phenom-World, a desktop scanning electron microscopy solutions company based in the Netherlands. Thermo Fisher will integrate the business into its Analytical Instruments segment. Terms of the transaction were not disclosed.
HHS

Hot Stocks

15:18 EDT Harte-Hanks announces reverse-split ratio, effective date - Harte Hanks announced that its board had adopted a 10-for-1 reverse split ratio for the reverse split approved by the company's stockholders at the special meeting held December 14. The reverse split will be effected January 31, 2018.
DIS...

Hot Stocks

14:14 EDT Box Office Battle: 'Last Jedi' again expected to come in first - Expected to retain the top spot for the third weekend in a row is Disney's (DIS) "Star Wars: The Last Jedi," which is expected to domestically gross around $57M this weekend, which should push it over "Beauty and the Beast" as this year's highest grossing film. "Beauty and the Beast," also from Disney, had a total domestic gross of just over $504M. The next three box office spots are likely to be taken by last weekend's new releases -- Sony's (SNE) "Jumanji: Welcome to the Jungle," 21st Century Fox's (FOX, FOXA) "The Greatest Showman," and Comcast (CMCSA, CMCSK) subsidiary Universal's "Pitch Perfect 3." "Jumanji" is expected to earn $30M-$40M, "Pitch Perfect 3" is expected to earn just over $20M, and "Greatest Showman" is expected to earn about $10M. Expected to round out the top five is Fox's animated family film "Ferdinand," which is looking to make about $8M in its third weekend at theaters. Other publicly traded companies in filmmaking include Lionsgate (LGF.A, LGF.B), Time Warner (TWX), and Viacom (VIA, VIAB).
CHFC

Hot Stocks

14:11 EDT Chemical Financial doesn't see future cash expenditures due to reduced DTA - In a regulatory filing, Chemical Financial said: "The Corporation's revaluation of its deferred tax asset is subject to further clarifications of the new law that cannot be estimated at this time. As such, the Corporation is unable to make a final determination of the impact on the quarterly and year-to-date earnings for the period ending December 31, 2017 at this time, and, therefore, the reduction of the Corporation's deferred tax asset may vary materially from the estimated amount. The Corporation does not anticipate future cash expenditures as a result of the reduction to the net deferred tax asset."
CHFC

Hot Stocks

14:09 EDT Chemical Financial sees $55M impact in Q4 from Tax Cuts and Jobs Act - In a regulatory filing, Chemical Financial reported that it is completing a revaluation of the corporation's net deferred tax assets following the signing of the "Tax Cuts and Jobs Act" into law. "The Corporation is currently in the process of evaluating the impact of H.R.1 and has preliminarily estimated a reduction in the Corporation's deferred tax asset of approximately $55M in the fourth quarter of 2017, representing approximately (77c) per diluted share based on estimated fourth quarter weighted average diluted shares of approximately 71M," Chemical stated.
BTC...

Hot Stocks

13:21 EDT The Intersection: Crypto and Wall Street This Week - As bitcoin, ethereum and other cryptocurrencies get increasing attention from investors, Wall Street and its traditional banks continue to adjust to the shift. Catch up on this week's top stories highlighting the intersection of these old guard and new school areas of finance with this recap compiled by The Fly: 1. S. KOREA TO REQUIRE REAL NAMES: Hong Nam-ki, South Korean minister of the Office for Government Policy Coordination, announced the country would ban the use of anonymous virtual accounts in cryptocurrency transactions as the government "can't let this abnormal situation of speculation go on any longer," the Korea Herald reported Thursday. Under the ban only real-name bank accounts and matching virtual accounts can be used for deposits and withdrawals and exchanges will be barred from issuing new accounts to clients. Hong also said the government will bolster requirements of local exchanges to avoid money-laundering and put restrictions on cryptocurrency advertisements. He added the justice ministry has suggested shuttering cryptocurrency exchanges. Following the announcement, Bitcoin dropped below $14,000. 2. MORGAN STANLEY SAYS MAY HAVE ZERO VALUE: On Tuesday, Morgan Stanley analyst James Faucette suggested that the real value of bitcoin may be zero dollars as there is "virtually no acceptance" of the cryptocurrency by e-commerce merchants, Business Insider reported. He added Bitcoin is not a currency as it has no associated interest rate and it has no intrinsic use like gold has in electronics or jewelry. He sees the digital currency as a payment network, but one that is tough to scale. He did not give a price target for the cryptocurrency. 3. WIDE RANGE PREDICTION: On Wednesday, DataTrek Research analyst Nick Colas initiated coverage of Bitcoin and said he expects 2018 to be another volatile year for the digital currency. He predicted that Bitcoin will trade between $6,500 and $22,000 in the coming year with a midpoint range of $14,035. He also forecasted that bitcoin will lose more market share to rivals and experience "at least four crashes" of 40% or more. "Bitcoin and cryptocurrency are hard to value and their economic utility relies on use cases that are not yet built. Of course the volatility we've seen will continue," he said. 4. ISRAEL SEEKS BAN OF CRYPTO COMPANY LISTINGS: The Israel Securities Authority is planning to seek a ban on new listings of companies based on bitcoin and other cryptocurrencies on the Tel Aviv Stock Exchange, Reuters reported Monday. The regulator is also looking to suspend trading for companies currently listed as it considers appropriate regulation for the businesses. The exchange currently has at least two digital currency companies listed, Blockchain Mining and Fantasy Network. "We feel that the prices of bitcoin behave like bubbles and we don't want investors to be subject to that volatility and uncertainty," chairman Shmuel Hauser said. 5. INDIA LIKENS CRYPTO TO "PONZI SCHEMES": India's Finance Ministry announced that cryptocurrencies are not legal tender and have no regulatory permission or protection in the country, Reuters reported on Friday. The ministry said investors who deal with the digital currency are doing so "entirely at their risk and should best avoid participating therein," adding, "There is a real and heightened risk of investment bubble of the type seen in Ponzi schemes." 6. CRYPTO CHATTER: On Wednesday, William Galvin, the secretary of the Commonwealth of Massachusetts said Bitcoin "doesn't pass the smell test," CNBC reported. "There is no product here. This is entirely speculation. That's already been proven by the high gyrations of the value," Galvin said. "It's also subject to manipulation, because no one can explain it no one can control it." Additionally, Wolfgang Koester, CEO of currency analytics provider FiREapps said existing digital currencies are not yet suitable for companies, CNBC reported on Thursday. The volatility is "too speculative for corporations," he said, "They are saying we can't get involved with bitcoin, but we like the idea of bitcoin and others. We like speedy transactions at a lower cost." He said companies "are waiting for governments to issue those digital currencies, so they can take advantage." On Friday, investor Dennis Gartman told other investors to "stay the heck away from bitcoin," CNBC reported. "It makes no sense whatsoever. I won't trade it. I won't be long of it. I won't be short of it," he said. 7. BITCOIN STOCK PLAYS: Cryptocurrency revenues have been pointed to as reasons to be bullish on Advanced Micro Devices (AMD) and Nvidia (NVDA) in select research. Overstock (OSTK), Digital Power (DPW), Long Island Iced Tea (LTEA), Seven Stars Cloud Group (SSC), Riot Blockchain (RIOT), Longfin (LFIN), Pareteum (TEUM) and Social Reality (SRAX) are other stocks that have been touted, or promoted themselves, as a way to play the crypto theme. PRICE ACTION: As of time of writing, bitcoin rose nearly 9.9% this week to $14,702.68 in U.S. dollars according to CoinDesk. Meanwhile, Digital Power dropped 35.3% to $3.33, Long Island Iced Tea rose about 158% to $5.32, Seven Stars Cloud Group was up 13.9% to $4.76, Longfin rose 25.4% to $57.57 and Pareteum surged about 187% to $2.26 all on a weekly basis. Bitcoin Investment Trust was up about 52% this week to $2,050. WANT BITCOIN NEWS ALERTS?: To receive alerts on stories relating to bitcoin and other cryptocurrencies, Fly subscribers can enter "Bitcoin" into the "Add symbols" box of their portfolios.
BHGE

Hot Stocks

13:03 EDT Baker Hughes reports U.S. rig count down 2 to 929 rigs - Baker Hughes reported the U.S. rig count is down 2 rigs from last week to 929, with oil rigs unchanged at 747, gas rigs down 2 to 182, and miscellaneous rigs unchanged.
VRX

Hot Stocks

13:00 EDT Valeant announces preliminary resolution of Allergan shareholder lawsuits - Valeant Pharmaceuticals announced the parties in the cases of Basile v. Valeant Pharmaceuticals International and Timber Hill LLC v. Pershing Square Capital Management in the U.S. District Court for the Central District of California have preliminarily agreed to resolve the claims of the litigation for $290M, subject to the court's approval. Valeant will pay $96.25M, or 33%, of the settlement under the terms of a recently revised Litigation Management Agreement with the other defendants. Additionally, as part of the agreement, the company and the other defendants admit no wrongdoing. "We believe this agreement to resolve the legacy litigation is in the best interests of the Company, because it enables us to focus our attention and resources on the transformation of Valeant. Though we always have remained confident in our position and were prepared to try these cases on their merits, this agreement will eliminate disruption to our business," said Valeant chairman and CEO Joseph Papa.
VRX AGN

Hot Stocks

12:46 EDT Pershing to pay $193.75M, Valeant to pay $96.25M to settle lawsuits - Pershing Square announced that it has reached an agreement in principle, subject to court approval, to settle lawsuits concerning the attempted acquisition of Allergan (AGN) by Pershing Square Capital Management and Valeant Pharmaceuticals (VRX) in 2014, which were filed in the Central District of California. Pershing Square and Valeant have agreed to split the $290M total settlement such that Pershing Square will pay $193.75M and Valeant will pay $96.25M. Pershing says, "While Valeant had originally agreed to pay 60% of the cost of the settlement, Valeant and Pershing Square had different views on the desirability and timing of settling the case, which previously prevented settlement. On December 19, 2017, Pershing Square acquired control of the settlement of the litigation in exchange for agreeing to pay a greater percentage of the settlement amount." Pershing Square CEO Bill Ackman adds, ""We continue to believe the case had absolutely no merit. We decided, however, that it was in the best interest of our investors to settle the case now instead of continuing to spend substantial time and resources pursuing the litigation." Pershing Square had previously set aside $75M in legal reserves related to the case. The incremental cost of settling the litigation will reduce the company's and the private funds' performance and net asset value by 132 basis points.
ENTL SYK

Hot Stocks

12:29 EDT Sand Grove takes stake in Entellus Medical after buyout - Sand Grove Capital Management disclosed a 5.18% stake in Entellus Medical (ENTL), which represents over 1.32M shares. The filing allows for activism. The company on December 7 agreed to be acquired by Stryker (SYK) for $24 per share in cash.
ADTN...

Hot Stocks

11:13 EDT Telecom equipment providers fall after Adtran cuts guidance - Telecommunications equipment companies are falling after Adtran (ADTN) issued guidance for its fourth and first quarters this morning, GUIDANCE: Adtran revised revenue and earnings estimates for Q4 ending December 31, forecasting adjusted earnings per share of roughly 1c on revenue of $125M. Previous guidance saw Q4 revenue between $155M-$165M. The guidance compares to analyst estimates of 14c and $161.28M, respectively. The company added that current expectations for Q1 will be in the range of this quarter, which compares to analyst estimates of $167.53M. ADTRAN CEO Tom Stanton said, "Our performance this quarter has been significantly impacted by a merger-related review and slowdown in the spending at a domestic Tier 1 customer. Our current understanding is that this review will be completed in 60 to 90 days, at which time capital plans will be finalized. Going forward, recent awards and trials in Tier 1 customer accounts, both domestically and abroad, leave us very confident about our positioning." ANALYST REACTION: Following the announcement, MKM Partners analyst Michael Genovese lowered his price target on Adtran to $25 from $27, citing the company's reduced Q4 guidance. Genevese said this customer is likely CenturyLink (CTL), which accounted for 24% of Adtran's total sales in 2016 and was likely Adtran's largest customer in 2017. The analyst notes this weakness is likely to be temporary, adding that Adtran performance will likely accelerate into 2019 as the company stands to benefit from 5G spending. He added that he expects the net neutrality repeal and tax reform to be beneficial to telecommunications capital expenditures spending. Genovese keeps his Buy rating on Adtran. Meanwhile, Lake Street analyst Jaeson Schmidt said Adtran's lowered Q4 outlook is a net negative for Clearfield (CLFD). A muted spending environment could create headwinds for the company in the first half of fiscal 2018, but he added that he still likes Clearfield longer term. Schmidt kept a Buy rating on Clearfield shares. COMPETITORS: In its most recent 10-K filing, Adtran listed its Network Solutions competitors as Aerohive Networks (HIVE), Arris (ARRS), Calix (CALX), Ciena (CIEN), Cisco (CSCO), Edgewater Networks, Fujitsu Network Communications (FJTSY), Hewlett Packard Enterprise (HPE), Huawei Technologies, Nokia (NOK), Brocade Communication's (BRCD) Ruckus Wireless, Ubiquiti Networks (UBNT), DASAN Zhone Solutions (DZSI) and ZTE Corporation (ZTCOY). The company also said it competes with various original design manufacturer vendors who are being engaged directly by some of service provider customers and added Services & Support competitors included Ericsson (ERIC), Fujitsu, Nokia, and Calix. PRICE ACTION: Adtran dropped 14% to $19.12, Clearfield fell 1.2% to $12.20, Calix was down 5.1% to $6.03, Ciena dropped 2.2% to $20.93 and Dasan Zhone Solutions fell 1% to $9.31 in morning trading.
MYL

Hot Stocks

10:54 EDT Mylan announces U.S. launch of Estradiol Vaginal Cream USP, 0.01% - Mylan N.V. announced the U.S. launch of Estradiol Vaginal Cream USP, 0.01%, the first generic version of Allergan's Estrace Cream. Mylan received final approval from the FDA for its Abbreviated New Drug Application, or ANDA, for this product, which is indicated in the treatment of vulvar and vaginal atrophy.
BCR BDX

Hot Stocks

10:53 EDT Becton Dickinson announces completion of C. R. Bard acquisition - Becton Dickinson (BDX) announced it has completed the acquisition of C. R. Bard (BCR), creating a new health care company with approximately $16B in annualized revenue. Under the terms of the transaction, upon completion of the acquisition, Bard became a wholly owned subsidiary of BD, and each outstanding share of Bard common stock was converted to the right to receive $222.93 in cash without interest and 0.5077 of a share of BD common stock. As a result of the completion of the acquisition, Bard shares will cease trading and will be delisted from the NYSE. Excluding transaction-related expenses, BD does not expect the acquisition to have a material impact on the company's financial results in the first quarter of FY18, which ends on Dec. 31, 2017. The company continues to expect the transaction to generate low-single digit accretion to adjusted EPS in FY18, and high-single digit accretion in FY19. The company will provide an update to its full FY18 outlook on its first fiscal quarter earnings conference call to reflect the anticipated contribution from Bard's operations through BD's fiscal year.
TIVO

Hot Stocks

10:00 EDT TiVo surges after TheStreet says PE bidders offering over $20 per share - TiVo shares have jumped in morning trading after TheStreet reported that it was told by a person familiar with the situation that the company has received "multiple" expressions of interest from private equity firms that have made takeover bids of "slightly more than $20 a share." Following TheStreet's report, TiVo shares are up $1.29, or 9.2%, to $15.29 per share. Reference Link
APDN

Hot Stocks

09:56 EDT Applied DNA Sciences jumps after discussing blockchain plans - Shares of micro-cap Applied DNA Sciences is jumping in early trading after the company discussed its plans to use blockchain technology with its molecular tagging in the authentication of physical goods. Additionally, after the close last night, Applied DNA Sciences reported that its FY17 revenues increased 13% to $4.8M, as compared to $4.2M in the prior fiscal year. Net loss for FY17 was $12.9M, or (49c) per share, compared with a net loss of $12.2M, or (51c) per share, in the prior fiscal year. In early trading, Applied DNA shares are up 21c, or 12%, to $1.92.
WATT

Hot Stocks

09:43 EDT Energous falls after Citron predicts retreat to $15 share level - Citron Research just tweeted, "$WATT Co has a history of deception and the recent FCC info is no different. Tech is not ready for primetime and the loss of Apple for Dialog, death to the rumor. Roth upgrade was as ridic as their defense of Unipixel until BK. Powercast at CES will expose why $WATT to $15." Shares of Energous are down 10% to $28.30.
GALE

Hot Stocks

09:29 EDT Galena announces stockholder approval of SELLAS Life Sciences merger - Galena Biopharma announced that its stockholders approved nine proposals at the reconvened Special Meeting of Stockholders held at 9:00 a.m. Eastern Time on December 29, 2017, including all proposals necessary to approve the business combination transaction in which the businesses of Galena and SELLAS Life Sciences Group, are expected to be combined. One proposal, regarding approval of an amendment to Galena's Certificate of Incorporation to allow the Galena board of directors to approve amendments to Galena's bylaws, was not approved. The failure of stockholders to approve this proposal has no impact on the Merger.Stockholders approved an amendment to the Galena Amended and Restated Certificate of Incorporation to effect a reverse stock split of the issued shares of the Galena common stock, at a ratio of not less than 1-for-10 and not greater than 1-for-30, with the exact ratio and effective time of the reverse stock split to be determined by the Galena board of directors and agreed upon by SELLAS. Galena's Board of Directors has determined, and SELLAS has agreed, to effect the reverse stock split of the Galena common stock at a ratio of 1-for-30. Therefore, every 30 shares of Galena common stock issued and outstanding or held by Galena in treasury immediately prior to the effective time of the reverse stock split will automatically be reclassified at the effective time into one fully paid and nonassessable share of Galena common stock. The reverse stock split is expected to become effective at 4:15 p.m. Eastern Time today, December 29. Subject to the satisfaction of customary closing conditions, the Merger is expected to close shortly following the effectiveness of the reverse stock split. Assuming effectiveness of the reverse stock split and closing of the Merger today, the common stock of the continuing company, which will be renamed SELLAS Life Sciences Group will commence trading on the NASDAQ Capital Market on a post-reverse stock split basis under the new symbol "SLS" on Tuesday, January 2, 2018.
ANIP AZN

Hot Stocks

09:25 EDT ANI Pharmaceuticals acquires 4 NDAs from AstraZeneca for $46.5M - ANI Pharmaceuticals (ANIP) announced that it has acquired the NDAs and U.S. rights to market ATACAND, ATACAND HCT, ARIMIDEX, and CASODEX from AstraZeneca (AZN) for $46.5M in cash, royalties, and sales-based milestones. AstraZeneca will continue to market and supply ATACAND, ATACAND HCT, ARIMIDEX, and CASODEX outside of the U.S. The acquired assets include the NDAs for all four products and a license to their trademarks. The acquisitions were funded through a combination of cash and debt.
AZN...

Hot Stocks

09:17 EDT On The Fly: Pre-market Movers - HIGHER: AstraZeneca (AZN), up 1.9% after being upgraded to Overweight from Neutral at JPMorgan... T-Mobile (TMUS), up marginally after CEO John Legere made a list of 2018 predictions in his New Year address. LOWER: Adtran (ADTN), down 16.6% after providing updated fourth quarter guidance... Amazon.com (AMZN), down marginally, after President Trump tweeted the U.S. Postal Service should be charging the company "much more."
SSY

Hot Stocks

09:11 EDT SunLink Health, Southern Health Corporation of Houston complete pay-down - SunLink Health Systems and its wholly-owned subsidiary, Southern Health Corporation of Houston completed their previously-announced modification and pay-down of Trace's Department of Agriculture Rural Development Loan. Under the modification, Trace has made a $3,548,000 prepayment on the RDA Loan which will reduce the principal balance to approximately $3,500,000 at December 31, 2017. The lender has reduced the monthly principal payments on the RDA Loan to $39,050 per month, has reduced the interest rate on the loan to the prime rate plus 1% with a floor of 5.5%, and has modified certain loan covenants, including a waiver of covenant violations for the quarters ended June 30 and September 30, 2017. The Company expects to report a loss on early extinguishment of debt of approximately $238,000 as of December 31. In connection with the modification and prepayment, an existing deposit of $1,000,000 in a blocked, interest bearing account with the lender has been released. There can be no assurance the modification will result in Trace being able to achieve compliance with the modified loan covenants in future periods.
CMA

Hot Stocks

09:10 EDT Comerica to raise minimum wage to $15/hour, award $1,000 bonus to non-officers - Comerica announced its plan to further invest in its colleagues by increasing its minimum wage to $15 per hour, effective January 5, 2018, and paying approximately 4,500 non-officer colleagues, more than half of its colleague population, a one-time bonus of $1,000 in January 2018. This increase in minimum wage and one-time bonus are made possible by the new U.S. tax reform law.
BCR

Hot Stocks

08:56 EDT C.R. Bard trading halted, news dissemination
APT

Hot Stocks

08:51 EDT Alpha Pro Tech names Lloyd Hoffman president - Alpha Pro Tech announced that the Board of Directors has appointed Lloyd Hoffman as president of the company, and has appointed Donna Millar as a member of the Board of Directors of the company, both succeeding Alexander Millar, former president and chairman of the company who passed away on December 16. The appointments are effective immediately. Hoffman will continue in his current role as the company's CEO.
PGNX

Hot Stocks

08:34 EDT Progenics announces FDA acceptance of NDA for AZEDRA - Progenics Pharmaceuticals announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for AZEDRA in patients with malignant, recurrent and/or unresectable pheochromocytoma and paraganglioma, which are rare neuroendocrine tumors. The FDA granted Progenics' request for Priority Review and has set an action date of April 30, 2018 under the Prescription Drug User Fee Act (PDUFA). The NDA is supported by data from a pivotal phase 2b open-label, multi-center trial that was conducted under a Special Protocol Assessment with the FDA. The trial met the primary endpoint evaluating the proportion of pheochromocytoma and paraganglioma patients who achieved a 50% or greater reduction of all antihypertensive medication for at least six months, and showed favorable results from a key secondary endpoint evaluating the proportion of patients with overall tumor response as measured by Response Evaluation Criteria In Solid Tumors. AZEDRA was also shown to be safe and generally well tolerated.
AMZN...

Hot Stocks

08:33 EDT Amazon shares dip after Trump calls for higher postage fees - Shares of Amazon.com (AMZN) moved lower in premarket trading after President Donald Trump called on the U.S. Postal Service to increase the rates it charges the online retailing giant. Trump tweeted this morning, "Why is the United States Post Office, which is losing many billions of dollars a year, while charging Amazon and others so little to deliver their packages, making Amazon richer and the Post Office dumber and poorer? Should be charging MUCH MORE!" Shares of Amazon, after rising earlier in the premarket session, are now down $4.20 to $1,181.94. Shippers FedEx (FDX) and UPS (UPS) are little changed in premarket trading.
CUBN

Hot Stocks

08:31 EDT Commerce Union Bancshares to change name to Reliant Bancorp - Commerce Union Bancshares announced that it will change its name to Reliant Bancorp, Inc. effective December 31, 2017. The change will precede the company's pending merger with Community First, the parent company for Community First Bank & Trust located in Columbia, Tennessee, which is expected to be completed on January 1, 2018. The company's stock will begin trading under the new ticker symbol "RBNC" on January 2, 2018, the first day of trading in the new year.
AMZN

Hot Stocks

08:10 EDT Trump says USPS should be charging Amazon 'MUCH MORE' - President Donald Trump just tweeted: "Why is the United States Post Office, which is losing many billions of dollars a year, while charging Amazon and others so little to deliver their packages, making Amazon richer and the Post Office dumber and poorer? Should be charging MUCH MORE!" Reference Link
CIFS

Hot Stocks

08:05 EDT CINFS signs strategic partnership agreement with CCFT - China Internet Nationwide Financial Services announced that it has entered into a strategic cooperation agreement with China Co-op Foreign Trade, or CCFT, a majority-owned subsidiary of All China Federation of Supply and Marketing Cooperatives. Pursuant to the Agreement executed on December 26, the two parties will explore cooperation opportunities including the joint development of a big data center for China's Co-op and agricultural-related industries, a settlement center in support of the One Belt One Road Initiative, as well as designating the company as a preferred partner in providing data analytics and financing advisory services to China Co-op's network of cooperatives and affiliated enterprises.
TEUM

Hot Stocks

08:03 EDT Pareteum appoints Ali Davachi as Chief Technology Officer, COO - Pareteum announced that it has appointed Ali Davachi as Pareteum's Chief Technology Officer and Chief Operating Officer. Most recently, Davachi was Founder and CEO of Realware LLC, an enterprise IT and development firm.
ALBO

Hot Stocks

08:02 EDT Albireo Pharma announces inducement grants under Nasdaq listing rule - Albireo Pharma announced the grant to two employees of inducement stock options exercisable for an aggregate of 37,000 shares of Albireo's common stock. The stock options are exercisable at a price of $26.12 per share, the closing price of Albireo's common stock on December 28, 2017, the grant date, and were granted as inducements material to each employee's acceptance of employment with Albireo in accordance with Nasdaq Listing Rule 5635(c)(4). Each stock option has a 10-year term and vests over a four-year period, subject to the employee's continued service with Albireo through the applicable vesting dates. The vesting schedule for each stock option is 25 percent on the one-year anniversary of the employee's start date with Albireo and 75 percent in equal installments on the last day of the 12 consecutive quarters beginning with December 31, 2018. The stock options are subject to the terms and conditions of Albireo's 2017 Inducement Equity Incentive Plan
TGEN

Hot Stocks

08:01 EDT Tecogen Co-CEO John Hatsopoulos to retire, will continue in advisory role - Tecogen announced that John Hatsopoulos, the company's Co-CEO and co-founder, has decided to retire as an officer and not run for re-election to the board of Tecogen Inc. at the 2018 annual meeting. He will remain a director of American DG Energy, or ADGE, and Ultera Technologies, Inc. He will also continue to be actively involved with the company as an advisor to the board and Co-CEO Benjamin Locke and as an employee responsible for investor relations. Upon his retirement, Hatsopoulos will assume the title of Chairman Emeritus.
ZAYO

Hot Stocks

08:01 EDT Zayo Group selected by ad tech company for colocation - A leading ad tech company has selected Zayo Group Holdings for data center colocation and IP connectivity. Zayo will provide expanded colocation space in its Oak Brook and Ashburn data centers by more than 50 cabinets along with IP connectivity. As this customer has rapidly grown over the past few years, so has their need for high-capacity, reliable infrastructure for their data-intensive, latency sensitive solutions. The additional purchase of colocation space and power now makes this company one of Zayo's largest colocation customers.
KFRC

Hot Stocks

07:34 EDT Kforce sees 24c-28c negative impact to Q4 EPS from U.S. tax reform law - Kforce announced that it expects to record a one-time, non-cash charge in Q4 as a result of the recently enacted Tax Cuts and Jobs Act, or TCJA. This charge results solely from the revaluation of our net deferred income tax assets as of December 31, 2017 and was not anticipated in the company's previously announced guidance of 41c-43c per share. The negative impact to net income from the revaluation is estimated to be between $6M-$7M, or approximately 24c-28c per share. Kforce anticipates subsequent regulations and interpretations to be released associated with TCJA that will provide additional guidance on the application of the law; however, we currently estimate that Kforce's effective income tax rate will be in the range of 25.5%-27.5% for 2018 compared to approximately 38% for 2017.
BDRBF

Hot Stocks

07:11 EDT Bombardier announces customer order for 6 CRJ900 aircraft, option for 6 more - Bombardier Commercial Aircraft announced that a customer, who has requested to remain unidentified at this time, has signed an order to acquire six CRJ900 aircraft on firm order and options on six additional CRJ900 regional jets. Based on list price, the firm orders would be valued at approximately $290M. Should the customer exercise the six options for CRJ900 aircraft, the contract value would increase to approximately $580M.
AVA

Hot Stocks

07:07 EDT Avista receives approval of muli-party settlement in Idaho general rate case - Avista received approval from the Idaho Public Utilities Commission on the multi-party settlement that was filed on Oct. 23, concluding the company's electric and natural gas general rate cases filed on June 9. New rates will take effect on Jan. 1, 2018 and Jan. 1, 2019. The approved rates are designed to increase annual billed electric revenues by $12.9M, or 5.6%, effective Jan. 1, 2018, and by $4.5M, or 2.3% effective Jan. 1, 2019. For natural gas, the approved rates are designed to increase annual billed revenues by $1.2M or 1.9%, effective Jan. 1, 2018, and by $1.1 million, or 1.8 percent on Jan. 1, 2019. The approved revenue increases are based on a 9.5 percent return on equity with a common equity ratio of 50 percent.
TMUS CHTR

Hot Stocks

07:02 EDT T-Mobile CEO says company on 'fast track to nationwide 5G network in 2020' - T-Mobile (TMUS) CEO John Legere makes a list of 2018 predictions in his New Year address titled "The Revolution Continues". Among his predictions, he expects Charter (CHTR) to enter the wireless space. He also states: "We'll continue to grow and strengthen our LTE coverage today, and second, we announced we'd use part of that spectrum to build nationwide 5G... While Dumb and Dumber focus on 5G hotspots that won't work when you leave your home, we will be the only ones on the fast-track toward a real, mobile nationwide 5G network in 2020 - and have already started deploying 5G ready equipment." Reference Link
GWPH

Hot Stocks

07:02 EDT GW Pharmaceuticals submits MAA for Epidiolex - GW Pharmaceuticals announced it has submitted its Marketing Authorisation Application to the European Medicines Agency for Epidiolex as adjunctive treatment for seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two highly treatment-resistant forms of childhood-onset epilepsy. GW has received Orphan Designations from the EMA for Epidiolex for the treatment of LGS, Dravet syndrome, and recently, West syndrome and Tuberous Sclerosis Complex. In October 2017, GW completed the submission of its rolling Epidiolex New Drug Application to the United States Food and Drug Administration, also for seizures associated with LGS and Dravet syndrome. This NDA has been accepted by the FDA for Priority Review. The MAA for Epidiolex is supported by data from three Phase 3 safety and efficacy studies, each of which met their primary endpoint. Epidiolex was generally well tolerated in these trials. The MAA includes safety data on approximately 1,500 patients, with approximately 400 patients on continuous therapy for more than one year. Approximately 26% of the Epidiolex patients from the Phase 3 pivotal program came from European sites. Beyond pivotal safety and efficacy data, the MAA includes a comprehensive clinical pharmacology, pre-clinical and toxicology package.
TMUS

Hot Stocks

07:01 EDT T-Mobile CEO says company on 'fast track to nationwide 5G network in 2020' - T-Mobile CEO John Legere makes a list of 2018 predictions in his New Year address titled "The Revolution Continues". Among his predictions, he expects Charter (CHTR) to enter the wireless space. He also states: "We'll continue to grow and strengthen our LTE coverage today, and second, we announced we'd use part of that spectrum to build nationwide 5G... While Dumb and Dumber focus on 5G hotspots that won't work when you leave your home, we will be the only ones on the fast-track toward a real, mobile nationwide 5G network in 2020 - and have already started deploying 5G ready equipment." Reference Link
RXDX

Hot Stocks

07:01 EDT Ignyta receives FDA clearance of IND for RXDX-106 - Ignyta announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for RXDX-106, a novel oral immunomodulatory agent and TAM inhibitor, in patients with solid tumors. Under this IND, the company intends to initiate the TITAN study, a first-in-human, open label, multicenter, dose escalation study of RXDX-106 in patients with locally advanced or metastatic solid tumors. TITAN is designed to determine the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary clinical activity of RXDX-106.
SIVB

Hot Stocks

06:51 EDT SVB Financial sees tax legislation reducing value of related assets by $32M-$37M - In a regulatory filing, SVB Financial Group states that it is currently assessing the extensive changes under the Tax Cuts and Jobs Act and its overall impact on the company; however, based on its preliminary assessment of the reduction in the federal corporate tax rate from 35% to 21% to become effective on January 1, 2018, the company currently expects that its effective tax rate for 2018 will be between 27% and 30%. Such estimated range is based on management's current assumptions with respect to, among other things, the company's earnings, state income tax levels and tax deductions. The company's actual effective tax rate in 2018 may differ from management's estimate. The reduced applicable tax rate is expected to result in overall lower tax expense beginning in 2018, which will provide the company the opportunity to evaluate the potential utilization of a portion of the tax savings to increase or accelerate investments in its business, growth and employees. The reduction in the corporate tax rate under the TCJ Act will also require a one-time revaluation of certain tax-related assets to reflect their value at the lower corporate tax rate of 21%. As such, the company currently expects a reduction in the value of these assets of approximately $32 million to $37 million, which primarily relate to the company's net deferred tax assets and investments in low income housing tax credit funds. This estimated range of reduction in value is based on balances as of November 30, 2017, and the actual amount of reduction at the end of the fourth quarter of 2017 may differ, as it is dependent on, among other things, the final net deferred tax assets and low income housing tax credit fund investment balances as of December 31, 2017. Solely based on this estimated reduction in certain tax assets, the company expects an increase in the provision for income taxes of approximately $32 million to $37 million to be recognized in its income statement for the fourth quarter of 2017. Additionally, in connection with its ongoing treasury and tax management objectives, the company sold during the fourth quarter of 2017 approximately $573 million of fixed income investment securities in its available-for-sale securities portfolio, which resulted in a loss on investment securities of approximately $9 million, on a pre-tax basis. The proceeds from these sales of securities were reinvested in higher-yielding investments.
NFLX

Hot Stocks

06:43 EDT Netflix cites tax reform in boosting some executive salaries - Netflix disclosed last night the annual salaries and stock option allocation for 2018 for the company's executive officers. CEO Reed Hastings is making $700,000, CFO David Wells is making $2.8M, Chief Content Officer Ted Sarandos is making $12M, Chief Product Officer Greg Peters is making $6M and David Hyman is making $2.5M. The streaming service explained, "Salary for each Named Executive Officer, other than the Chief Financial Officer, that was over $1 million had a substantial surcharge to the Company under IRS rule 162. Thus, the Company created, and the shareholders approved, the Performance Bonus Plan for those whose salary the Company wanted to cap at $1 million to avoid the surcharges. With the recent passage of federal tax reform, the Plan will no longer eliminate such surcharge. As such, the Committee has determined that all cash compensation for 2018 will be paid as salary."
RENN

Hot Stocks

06:42 EDT Renren acquires U.S. trucking platform Trucker Path, terms not disclosed - Renren announced that it has entered into a definitive agreement to acquire 100% of Trucker Path Inc., a provider of a social platform for the trucking industry in the United States. Trucker Path's core product is the Trucker Path app, a trip planning companion for truck drivers, enabling a large driver community to assist each other in updating the real-time status of relevant points-of-interest on their route. It helps truckers find truck stops, available parking spots, rest areas, scales, open DOT weigh stations, truck washes and more. Expanding on the success of the Trucker Path app, Trucker Path also introduced the Truckloads app, a mobile marketplace providing freight load matching with over 3 million loads posted monthly. At present, Trucker Path has more than 600,000 monthly active users covering more than 33% of all U.S. long haul truck drivers and maintains steady organic growth. For Renren's global business, the acquisition of Trucker Path means an entry into the transportation sector. Going forward, Renren will continue exploring breakthroughs in this space, whether in intelligent transportation solutions or in autonomous vehicles.
MTL

Hot Stocks

06:31 EDT Mechel announces departure of CFO Sergey Rezontov - Mechel PAO reports that CFO Sergey Rezontov is leaving the company. Sergey Rezontov decided to leave the post of Mechel PAO's CFO for personal reasons.
GS

Hot Stocks

06:22 EDT Goldman Sachs sees tax legislation reducing Q4 earnings by $5B - Goldman Sachs says in a regulatory filing that the tax legislation signed by President Trump "significantly revises the U.S. corporate income tax by, among other things, lowering corporate income tax rates, implementing the territorial tax system and imposing a repatriation tax on deemed repatriated earnings of foreign subsidiaries." Goldman Sachs estimates, based on currently available information, that the enactment of the tax legislation will result in a reduction of approximately $5B in the firm's earnings for Q4 and year ending December 31, 2017, approximately two-thirds of which is due to the repatriation tax. The remainder includes the effects of the implementation of the territorial tax system and the remeasurement of U.S. deferred tax assets at lower enacted corporate tax rates. Goldman added, "The impact of the Tax Legislation may differ from this estimate, possibly materially, due to, among other things, changes in interpretations and assumptions the firm has made, guidance that may be issued and actions the firm may take as a result of the Tax Legislation."
WSR

Hot Stocks

06:20 EDT Whitestone REIT confirms receipt of notice of trustee nominations from KBS - Whitestone REIT confirmed that KBS SOR Properties, a wholly owned subsidiary of KBS Strategic Opportunity REIT, a non-traded real estate investment trust, submitted a notice on December 28, 2017 of its intent to nominate three individuals for election as Class III Trustees to the Whitestone Board of Trustees at the company's 2018 Annual Meeting of Shareholders. The company's Class III Trustees currently consist o James Mastandrea, Chairman and CEO, Nandita Berry, the 109th Secretary of State for Texas who was appointed to the Whitestone Board in September 2017, and Jack Mahaffey, formerly the President and CEO of Shell Mining Company. The Company issued the following statement: "The Whitestone Board and management team value the views of all of our shareholders, and continually review the company's strategic priorities and opportunities to enhance shareholder value. While we are open to and appreciate constructive feedback from our shareholders, KBS' Trustee nominations come as a surprise to us given our outstanding financial and operating performance over the last several years resulting in Whitestone producing total shareholder returns, or TSR, among the best in the publicly traded shopping center REIT industry. Whitestone's TSR ranking of the publicly traded shopping center REITs, per S&P Global Market Intelligence, is #1 of 17, #2 of 16 and #4 of 15, for the 1 Year, 3 Year and 5 Year periods1, respectively. Moreover, we find it unusual that KBS has not requested to meet with our management team to learn more about our unique business model and strategy or visit our community-centered properties before stating its intent to nominate Trustee candidates. Whitestone's Board has recently taken significant actions to enhance its corporate governance. Whitestone's Board is composed of seven highly qualified nominees, six of whom are independent and all of whom are actively engaged in overseeing the company's growth and success. With diversity and extensive financial, operational and strategic expertise, Whitestone's Board provides significant experience and oversight to ensure the company continues executing on its goals. To further enhance our corporate governance in 2017, we appointed three new independent trustees and adopted stock ownership guidelines for the Board and management team. Whitestone continues to execute its strategy to acquire, own, manage, develop and redevelop "internet resistant" neighborhood shopping centers that attract and retain customers by providing daily essential services and products not readily available online. We are pleased with the progress we have made so far, and will continue to take actions to advance these objectives and to create value for all Whitestone shareholders."
ATRA

Hot Stocks

06:04 EDT Atara Biotherapeutics to initiate two Phase 3 clinical studies - Atara Biotherapeutics announced that it received clearance from the FDA to initiate two Phase 3 clinical studies with tabelecleucel in patients with rituximab-refractory Epstein-Barr virus, or EBV, associated post-transplant lymphoproliferative disorder, or EBV+PTLD. The company plans to initiate these studies imminently. Tabelecleucel is Atara's off-the-shelf T-cell immunotherapy in development for the treatment of EBV+PTLD, as well as other EBV associated hematologic and solid tumors.
BDRBF

Hot Stocks

06:03 EDT Bombardier says EgyptAir converts LOI into firm order for 12 CS300 aircraft - Bombardier Commercial Aircraft and EgyptAir Holding Company announced today that the parties have executed a firm agreement for the sale and purchase of 12 CS300 aircraft along with purchase rights for an additional 12 CS300 aircraft. EgyptAir's Letter of Intent, or LOI, was previously announced on November 14 during the 2017 Dubai Air Show. Based on the list price of the CS300 airliner, the firm-order contract would be valued at approximately $1.1B. Should EgyptAir exercise the 12 purchase rights for CS300 aircraft, the contract value would increase to nearly $2.2B.
JAKK

Hot Stocks

06:01 EDT JAKKS Pacific CFO Joel Bennett to step down - JAKKS Pacific announced that Joel Bennett, the company's CFO, will be stepping down from his position at the company. The company also announced that it has commenced an external search to identify a new CFO. In order to arrange for a smooth transition, Bennett will continue as the company's CFO until completion of the company's annual report for the 2017 fiscal year or such earlier date that a successor has been named and transitioned to the office of CFO.
CTRP TCEHY

Hot Stocks

05:36 EDT Ctrip.com invested companies eLong, Tongcheng Network agree to merge - Ctrip.com (CTRP) announced that two of its investment portfolio companies, E-dragon Holdings, or eLong, and Tongcheng Network have entered into definitive transaction documents in connection with the merger of two companies as Tongcheng-Elong Holdings Limited, or Tongcheng-Elong. The transaction will be subject to customary closing conditions. Ctrip, along with Tencent Holdings Limited (TCEHY), will be the major strategic shareholders of Tongcheng-Elong. James Liang, Ctrip's Co-founder and Executive Chairman, will serve as the new company's Co-Chairman. Zhixiang Wu, Tongcheng Co-founder and Tongcheng Group CEO & Chairman, will also be Co-Chairman. Heping Ma, Tongcheng Co-founder and Tongcheng Network President and Hao Jiang, eLong CEO, will be Co-CEOs of the new company.
AXU

Hot Stocks

05:30 EDT Alexco Resource receives amendment to Water Use Licence from Yukon Water Board - Alexco Resource announced that it has received an amendment to its Water Use Licence from the Yukon Water Board for the development and operation of the Flame & Moth mine. The Flame & Moth underground mine, located adjacent to the existing Keno Hill District mill, comprises a potentially mineable 683,000 tonnes of 666 grams per tonne silver and is anticipated to be the primary production source for mine operations in the Keno Hill Silver District.
ADTN

Hot Stocks

05:28 EDT Adtran CEO says performance 'significantly impacted' by merger-related review - ADTRAN CEO Tom Stanton stated, "Our performance this quarter has been significantly impacted by a merger-related review and slowdown in the spending at a domestic Tier 1 customer. Our current understanding is that this review will be completed in 60 to 90 days, at which time capital plans will be finalized. Going forward, recent awards and trials in Tier 1 customer accounts, both domestically and abroad, leave us very confident about our positioning."